Evaxion Biotech (EVAX) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Evaxion Biotech has received a delisting determination from Nasdaq due to insufficient stockholder equity but has appealed the decision and requested a hearing to seek an additional 180-day extension. The company remains committed to maintaining its Nasdaq listing by increasing equity through business development and capital market activities. Despite challenges in the current market environment, Evaxion is in ongoing discussions with Nasdaq to regain compliance.
For further insights into EVAX stock, check out TipRanks’ Stock Analysis page.
